Healthcare enforcement saw an uptick in 2021 and in the first quarter of 2022 as the Department of Justice and other agencies ramped up their investigations following the COVID-19 slowdowns. This uptick in enforcement, combined with rulemaking and additional guidance, has given the healthcare industry much to monitor.

In this session, our healthcare-focused white-collar lawyers take a deep dive into the top issues impacting the healthcare industry today, and how leaders can proactively respond to these challenges and mitigate their enforcement risk, including:

• Implications of the Allergan decision for future False Claims Act cases
• State of COVID-19 enforcement
• Use of sub-regulatory guidance in enforcement matters, including the Garland Memo, the Good Guidance Rule and others
• Latest on opioids from the Centers for Disease Control

SPEAKER